Novel CD22 CAR-T therapy for paediatric leukaemia
16 Jun 2018
Novel CD22 CAR-T therapy for paediatric leukaemia
A new anti-CD22 CAR T immunotherapy for paediatric leukaemia
EHA Topics in focus : Immunotherapy
Novel ADC for relapsed/refractory lymphoma
iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia
Ribosomal lesions promote oncogenic mutagenesis
Phase II results of olaparib and abiraterone for mCRPC
Design and interim safety analysis of GeparX trial
Editor’s Choice for May 2018
The 2018 Myeloma Knowledge Exchange
Dealing with peripheral neuropathic pain in multiple myeloma
Managing infections in patients with multiple myeloma